Evidence map›Paper›PMID 30797686›Full record

ArticleMolecular cell2019

Continued Activity of the Pioneer Factor Zelda Is Required to Drive Zygotic Genome Activation.

Stephen L McDaniel, Tyler J Gibson, Katharine N Schulz, Meilin Fernandez Garcia, Markus Nevil, Siddhant U Jain, Peter W Lewis, Kenneth S Zaret, Melissa M Harrison

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Cohesin Facilitates Nucleosome Invasion by Transcription Factors.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Breaking anterior-posterior symmetry in the moth flybioRxiv : the preprint server for biology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Zelda is dispensable forMolecular biology of the cell · 2025
    Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Stephen L McDanielDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison WI 53706, USA.
Tyler J GibsonDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison WI 53706, USA.
Katharine N SchulzDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison WI 53706, USA.
Meilin Fernandez GarciaInstitute for Regenerative Medicine and Epigenetics Program, Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Markus NevilDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison WI 53706, USA.
Siddhant U JainDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison WI 53706, USA.
Peter W LewisDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison WI 53706, USA.
Kenneth S ZaretInstitute for Regenerative Medicine and Epigenetics Program, Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Melissa M HarrisonDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison WI 53706, USA. Electronic address: mharrison3@wisc.edu.
University of Wisconsin–Madison · USCalifornia Institute for Regenerative Medicine · USUniversity of Pennsylvania · US

Funding

GRADUATE TRAINING IN MOLECULAR BIOSCIENCEST32GM007215 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HULL, CHRISTINA M · 1985 to 2018
$22.5M
TRANS-ACTING FACTORS CAUSING CELL-SPECIFIC GENE CONTROLR01GM036477 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI ZARET, KENNETH · 1986 to 2023
$7.7M
Mechanisms of genomic reprogramming and transcriptional activation in the embryoR01GM111694 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HARRISON, MELISSA · 2015 to 2019
$1.6M
NIGMS NIH HHS R01 GM036477NIGMS NIH HHS R01 GM111694NIGMS NIH HHS T32 GM007215
6 · The paper itself

Abstract

Reprogramming cell fate during the first stages of embryogenesis requires that transcriptional activators gain access to the genome and remodel the zygotic transcriptome. Nonetheless, it is not clear whether the continued activity of these pioneering factors is required throughout zygotic genome activation or whether they are only required early to establish cis-regulatory regions. To address this question, we developed an optogenetic strategy to rapidly and reversibly inactivate the master regulator of genome activation in Drosophila, Zelda. Using this strategy, we demonstrate that continued Zelda activity is required throughout genome activation. We show that Zelda binds DNA in the context of nucleosomes and suggest that this allows Zelda to occupy the genome despite the rapid division cycles in the early embryo. These data identify a powerful strategy to inactivate transcription factor function during development and suggest that reprogramming in the embryo may require specific, continuous pioneering functions to activate the genome.

Indexed as

Cellular ReprogrammingAnimalsAnimals, Genetically ModifiedBinding SitesDNADrosophila melanogasterDrosophila ProteinsGene Expression Regulation, DevelopmentalGene SilencingNuclear ProteinsNucleosomesOptogeneticsProtein BindingS PhaseDNADrosophila ProteinsNuclear ProteinsNucleosomeszld protein, DrosophilaDrosophilamaternal-to-zygotic transitionMZToptogeneticpioneer factortranscriptionZeldaZGAzygotic genome activation

Identifiers

PMID30797686
PMCPMC6544384
OpenAlexW2917779347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.